Tercica, Inc.Brisbane, CA United States
Company Description
Hey, cut Tercica some slack -- it's feeling a bit hormonal. The company's drug therapies focus on the treatment of growth disorders. The company's lead product Increlex (rhIGF-1) treats children with severe primary insulin-like growth factor deficiency, and its Somatuline Depot (lanreotide) is for the treatment of acromegaly (excess growth hormones) in adults.
| 2000 Sierra Point Pkwy., Ste. 400 | Phone: 650-624-4900 | |
| Brisbane, CA 94005 | Fax: 650-624-4940 | 
Map This Company |
| United States |
Try a Full Premium Subscription
Access over 85 million companies
Call (866) 443-3939 or
Prepare for your Sales call
Try a Small Business Subscription
Starting $89 per month
Tercica, Inc. Rankings
Executives
| 42 executives listed for Tercica, Inc.'s Brisbane, CA location. | ||
| Chairman | Alexander Barkas | |
|---|---|---|
| President and COO | Richard King | |
| EVP Legal Affairs, General Counsel and Secretary | StephenRosenfield | |
Financials
| Company Type | SubsidiarySingle Location |
|---|---|
| Fiscal Year-End | December |
| Employees | 126 |
DNBiLeverage D&B's credit assessment tools to positively impact
your business. Get the scoop on Tercica, Inc. now.
- Reduce risk.
- Drive greater profitability.
- Increase cash flow.
